Tag: mild

An unpublished preprint of a study done by the Norwegian Institute of Public Health, NIPH, concludes that the AstraZeneca COVID-vaccine may lead to less severe bleeding disorders, and not only the very rare blood clotting side effects that have been widely reported. The researchers used an ongoing study called the Norwegian Mother, Father and Child

A Phase 2 clinical trial will evaluate the safety and efficacy of potential new therapeutics for COVID-19, including an investigational therapeutic based on synthetic monoclonal antibodies (mAbs) to treat the disease. Researchers sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, are working with clinical sites

A new study from Washington University School of Medicine in St. Louis supports evidence that children with mild asthma can effectively manage the condition by using their two inhalers—one a steroid and the other a bronchodilator—when symptoms occur. This is in contrast to the traditional method of using the steroid daily, regardless of symptoms, and

Researchers have shown that higher intelligence and younger age are predictors of greater cognitive recovery 2-5 years post-mild to severe traumatic brain injury (TBI). In contrast, injury severity, as measured by the duration of post-traumatic amnesia, was not associated with greater or worse long-term cognitive recovery, as supported by a study published in Journal of

A new study funded by the Department of Veterans Affairs (VA) and the Navy finds that veterans and service members with a history of combat-related mild traumatic brain injury—compared with those in a control group—have much higher levels of abnormally fast brain waves in a region that plays a key role in consciousness. The findings